跳至主要内容
临床试验/NCT01102647
NCT01102647已完成1 期

Assessment of Cholesterol Metabolism in Heterozygous Phytosterolemia

University of Manitoba2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
26
试验地点
2
主要终点
Decrease in plasma LDL-cholesterol

研究概览

简要总结

The purpose of the study is to examine the effect of plant sterols on cholesterol absorption and synthesis in people with heterozygous phytosterolemia.

详细描述

A plant sterol supplementation study will be conducted in individuals who are heterozygous for phytosterolemia compared to non-carriers. The study will use a double-blind, randomised, crossover, placebo-controlled design in which participants will consume 2 treatments including 1.6 g of plant sterol pills and a placebo pill, each for 4 weeks. A 4 week washout period will separate the two treatment periods. Plant sterol concentrations will be measured by gas liquid chromatography and absorption will be measured by the ratio of campesterol to lathosterol in plasma. Cholesterol absorption and synthesis will be measured by dual stable isotope technique, involving simultaneous administration of 13C-cholesterol and deuterium oxide, respectively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • heterozygous for phytosterolemia, wild-type.

排除标准

  • Pregnant,
  • Previous heart attack,
  • Kidney disease.

结局指标

主要结局

Decrease in plasma LDL-cholesterol

时间窗: 29 days

Other studies have found 10% reduction in plasma LDL-cholesterol after 2.2-3.2 gram of plant sterol supplementation for 4 weeks in heterozygous phytosterolemia.

次要结局

  • Increase plasma plant sterols(29 days)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验